首页> 外国专利> REPLICATION TYPE RECOMBINANT NOVEL CORONAVIRUS BASED ON VESICULAR STOMATITIS VIRUS VECTOR, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

REPLICATION TYPE RECOMBINANT NOVEL CORONAVIRUS BASED ON VESICULAR STOMATITIS VIRUS VECTOR, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

机译:基于囊泡口炎病毒载体的复制型重组新型冠状病毒,及其制备方法及其应用

摘要

A recombinant novel coronavirus based on a vesicular stomatitis virus vector, and a preparation method therefor and an application thereof. The recombinant novel coronavirus is a virus obtained by replacing a glycoprotein G of a vesicular stomatitis virus with an envelope protein S; the envelope protein S contains an envelope protein S extracellular domain of 2019-nCoV(SARS-CoV-2) or a partial sequence thereof. The recombinant novel coronavirus can simulate the process of invasion of 2019-nCoV(SARS-CoV-2) into cells, can stimulate an organism to produce an immune response against 2019-nCoV(SARS-CoV-2), can be used to study the infection process of 2019-nCoV(SARS-CoV-2), can also be developed into vaccines, and can be used to screen inhibitors for inhibiting virus intrusion, and develop vaccines.
机译:基于脉质口炎病毒载体的重组新型冠状病毒,及其制备方法及其应用。 重组新的冠状病毒是通过用封套蛋白质替换糖蛋白g的糖蛋白g而通过的病毒; 封套蛋白S含有2019-NCOV(SARS-COV-2)的包膜蛋白质S细胞外结构域或其部分序列。 重组新型冠状病毒可以模拟2019-NCOV(SARS-COV-2)进入细胞的侵袭过程,可以刺激对2019-NCOV(SARS-COV-2)产生免疫应答的生物体,可用于研究 也可以将2019-NCOV(SARS-COV-2)的感染过程开发成疫苗,并且可用于筛选抑制病毒侵扰的抑制剂,并开发疫苗。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号